Market Overview

Benzinga's Top Upgrades

Share:
Related MYL
Mylan Unveils Generic Avodart Capsules
Argus Sees Perrigo Going Lower After CEO Exit, Guidance Cut
Mylan launches generic version of Glaxo's Avodart in the U.S. (Seeking Alpha)
Related SHLM
Chowdhry: Everyone Wants To Be A Tesla Supplier
Mid-Day Market Update: U.S. Stocks Rise; Cree Shares Decline On Weak Outlook

Analysts at Canaccord upgraded Mylan (NASDAQ: MYL) from “hold” to “buy.” Mylan's shares closed at $25.00 yesterday. Mylan's trailing-twelve-month ROE is 15.70%.

Analysts at Longbow upgraded A. Schulman (NASDAQ: SHLM) from “underperform” to “neutral.” A. Schulman's shares closed at $25.14 yesterday. A. Schulman's PEG ratio is 0.79.

Analysts at Benchmark upgraded Expedia (NASDAQ: EXPE) from “hold” to “buy.” Expedia's stock closed at $51.25 yesterday. Expedia's trailing-twelve-month operating margin is 14.22%.

Analysts at RBC Capital upgraded PulteGroup (NYSE: PHM) from “sector perform” to “outperform.” PulteGroup's shares closed at $17.01 yesterday. PulteGroup's trailing-twelve-month revenue is $4.35 billion.

Latest Ratings for MYL

DateFirmActionFromTo
May 2016Leerink SwannMaintainsOutperform
Feb 2016Argus ResearchMaintainsBuy
Feb 2016Wells FargoInitiates Coverage onMarket Perform

View More Analyst Ratings for MYL
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (EXPE + MYL)

View Comments and Join the Discussion!